Absence of a Difference in the Neurosecretory Activity of Supraoptic Nucleus Vasopressin Neurons of Neuroleptic-Treated Schizophrenic Patients
- 1 January 2005
- journal article
- Published by S. Karger AG in Neuroendocrinology
- Vol. 82 (2), 63-69
- https://doi.org/10.1159/000090981
Abstract
Dysfunction in water intake and metabolism has frequently been reported in schizophrenia. The general population of schizophrenics under neuroleptic treatment secretes lower amounts of vasopressin than controls at comparable values of plasma osmolality. The purpose of the present study was to investigate the synthetic activity of vasopressin neurons of the dorsolateral supraoptic nucleus in schizophrenia on postmortem material using a battery of histochemical activity markers. Our material consisted of formalin-fixed and paraffin-embedded hypothalami from 5 schizophrenic patients under neuroleptic treatment and from 5 matched controls, obtained from The Netherlands’ Brain Bank. DSM-III or DSM-IV criteria were used for the clinical diagnosis. The histochemical markers used to study the neuronal activity of the magnocellular vasopressin-synthesizing neurons were: cell size, size of the Golgi apparatus, and expression of vasopressin and tyrosine hydroxylase mRNA by in situ hybridization. Morphometric evaluation and statistical analysis (Mann-Whitney U test) were performed. Our results showed no statistically significant differences in any of the neuronal activity markers between schizophrenic patients and controls. Therefore, the neurosecretory activity of vasopressin neurons of the dorsolateral part of the supraoptic nucleus does not appear to be changed in schizophrenic patients under medication. Since our sample did not include patients with reported polydipsia or hyponatremia, prospective investigation is needed to evaluate the above-mentioned neuronal activity markers in such a particular subgroup of schizophrenic patients.Keywords
This publication has 53 references indexed in Scilit:
- Features of Structural Brain Abnormality Detected in First-Episode PsychosisAmerican Journal of Psychiatry, 2000
- Vasopressin and Oxytocin Neurons of the Human Supraoptic and Paraventricular Nucleus; Size Changes in Relation to Age and SexJournal of Clinical Endocrinology & Metabolism, 1999
- Hyponatraemia and the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Induced by Psychotropic DrugsDrug Safety, 1995
- Colocalization of tyrosine hydroxylase with oxytocin or vasopressin in neurons of the human paraventricular and supraoptic nucleusDevelopmental Brain Research, 1994
- Atrial natriuretic peptide and arginine vasopressin secretion in schizophrenic patientsActa Psychiatrica Scandinavica, 1993
- Development of tyrosine hydroxylase-immunoreactive neurons in the human paraventricular and supraoptic nucleusDevelopmental Brain Research, 1993
- Immunocytochemical visualization of the Golgi apparatus in several species, including human, and tissues with an antiserum against MG-160, a sialoglycoprotein of rat Golgi apparatus.Journal of Histochemistry & Cytochemistry, 1990
- Development of vasopressin neurons in the human suprachiasmatic nucleus in relation to birthDevelopmental Brain Research, 1990
- Mechanisms of Altered Water Metabolism in Psychotic Patients with Polydipsia and HyponatremiaThe New England Journal of Medicine, 1988
- EVIDENCE FOR DOPAMINE AS AN INHIBITOR OF VASOPROTEIN RELEASE IN MANClinical Endocrinology, 1980